Please login to the form below

Not currently logged in
Email:
Password:

Ogilvy CommonHealth releases pharmacy report

The Power of Pharmacy debates its role and the change it faces

Ogilvy Commonhealth Worldwide 

Ogilvy CommonHealth Worldwide has released a new global report entitled The Power of Pharmacy.

The report examines why and how pharmacy is preparing for significant changes, based on insights from pharmacists in addition to opinions and predictions from the agency's pharmacy experts.

Gloria Gibbons, president of EAME Ogilvy CommonHealth Worldwide, commented: “In Europe alone there are more than 400,000 community pharmacists, with 46 million people visiting them each day. As the healthcare professional that is often closest to the public, their recommendations and advice have the power to truly change health behavior on a daily basis.

“In order to remain competitive, respond to increasing demands and juggle their dual responsibilities as retailers and healthcare professionals, we've found that pharmacists are seeking greater support so that they can better serve both customers and communities.”

The report also explores why pharmacy places centrally in the community and its increasing importance amongst customer, governments and manufacturers around the world. Pharmacists will be looking to the industry for assistance in fulfilling their role.

Gibbons added: “By looking ahead to the future, the report sparks interesting discussion on how tomorrow's pharmacists will deliver better healthcare for patients, whilst still running a successful retail business."

Ogilvy CommonHealth Worldwide is the health behaviour change specialist of Ogilvy & Mather.

Article by
Kirstie Pickering

1st April 2015

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...